[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Views 708
Citations 0
Correction
September 4, 2018

Incorrect Medication Reported

JAMA. 2018;320(9):938. doi:10.1001/jama.2018.11607

In the News From the Food and Drug Administration item entitled “Generic for Opioid Use Disorder,”1 published in the July 17, 2018, issue of JAMA, an incorrect medication was reported. In the second paragraph, the second sentence should have read as follows: “Buprenorphine, naltrexone, and methadone are FDA-approved to help patients who misuse opioids.” This article was corrected online.

References
1.
Voelker  R.  Generic for opioid use disorder.  JAMA. 2018;320(3):228.PubMedGoogle Scholar
×